World Journal of Emergency Medicine ›› 2023, Vol. 14 ›› Issue (5): 341-348.doi: 10.5847/wjem.j.1920-8642.2023.098
• Review Article • Next Articles
Open Access
Catherine V. Levitt1, Quincy K. Tran2,3(
), Hashem Hraky1, Maryann Mazer-Amirshahi4, Ali Pourmand1
Received:2023-08-18
Accepted:2023-09-10
Online:2023-10-30
Published:2023-09-01
Contact:
Quincy K. Tran, Email: Catherine V. Levitt, Quincy K. Tran, Hashem Hraky, Maryann Mazer-Amirshahi, Ali Pourmand. Emergency department approach to monkeypox[J]. World Journal of Emergency Medicine, 2023, 14(5): 341-348.
Add to citation manager EndNote|Ris|BibTeX
URL: http://wjem.com.cn/EN/10.5847/wjem.j.1920-8642.2023.098
Table 1.
Summary of common symptomatology in monkeypox infection
| Symptomatology | |
|---|---|
| Prior to rash eruption | |
| Days 2-3 Fever, weakness, fatigue, headache, myalgias, regional lymphadenopathy* | |
| Rash eruption | |
| Days 1-2 Macules to papules | |
| Days 3-4 Papules to vesicles | |
| Days 5-6 Vesicles to pustules | |
| Day 7 Pustules to umbilicated lesions | |
| Days 8-14 Umbilicated lesions to crusted lesions | |
| Common sites of rash | |
| Anogenital region | |
| Trunk and limbs | |
| Face and oral mucosa, tonsils, cornea, conjunctiva | |
Table 2.
A summary of recommendations for vaccination, limitation of spread, and treatment of mpox
| Recommendations |
|---|
| Vaccination |
| JYNNEOS*, ACAM2000 Prophylactic: administered as 2 doses, 28 d (approximately 4 weeks) apart Post exposure: within 4 d of known or suspected exposure Indicated for individuals at high risk: men who have sex with men (MSM), occupational sex workers, healthcare personnel (physicians, lab technicians) |
| Limitation of spread |
| Patient recommendations: quarantine 3-6 weeks; avoid of sexual contact; maintain hand hygiene; wear a mask; avoid touching eyes Physician recommendations: avoid direct contact with lesions; wear personal protective equipment (gown, gloves, eye protection, N95 mask); place patient in isolation; minimize staff interaction |
| Treatment Tecovirimat (intravenous and oral*): 200 mg capsules every 12 h for 14 d; indicated for patients with severe disease: ocular involvement, encephalitis, severe proctitis or pharyngitis, immunocompromised, children < 8 years, pregnant people Brincidofovir (oral): 400 mg capsules every 12 h for 14 d; indicated for patients with severe disease or risk of severe disease and unable to receive tecovirimat/have disease progression while on tecovirimat Cidofovir (intravenous and topical): topical 1% cream every 12 h for 7 d Trifluride 1% eyedrops: instilled every 2 h, up to 21 d; indicated for patients with ocular mpox Symptom management: pain - acetaminophen, ibuprofen, opioids if needed, viscous lidocaine mouthwash; itching - topical benzocaine/ lidocaine gel, calamine lotion, petroleum jelly, oral antihistamines |
Table 3.
Serious manifestations and complications of monkeypox by the body system
| Body system | Clinical exam finding |
|---|---|
| Ocular | Corneal scarring leading to blindness, keratitis |
| Genital | Rectal perforation, penile edema, paraphimosis, proctitis |
| Neurologic | Encephalitis |
| Pulmonary | Bronchopneumonia |
| Hematologic | Septicemia |
| Ear-nose-throat | Pharyngitis, obstructing lymphadenopathy |
| Dermatologic | Confluent and/or necrotic lesions |
| 1 |
Rani I, Goyal A, Shamim MA, Satapathy P, Pal A, Squitti R, et al. Prevalence of mpox viral DNA in cutaneous specimens of monkeypox-infected patients: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2023; 13:1179885.
doi: 10.3389/fcimb.2023.1179885 |
| 2 | World Health Organization. Mpox (Monkeypox). Available at: https://www.who.int/news-room/fact-sheets/detail/monkeypox |
| 3 |
Torres TS, Silva MST, Coutinho C, Hoagland B, Jalil EM, Cardoso SW, et al. Evaluation of mpox knowledge, stigma, and willingness to vaccinate for mpox: cross-sectional web-based survey among sexual and gender minorities. JMIR Public Health Surveill. 2023; 9:e46489.
doi: 10.2196/46489 |
| 4 | World Health Organization. WHO recommends new name for monkeypox disease. Available at: https://www.who.int/news/item/28-11-2022-who-recommends-new-name-for-monkeypox-disease |
| 5 |
Thakur M, Das P, Sobti RC, Kaur T. Human monkeypox: epidemiology, transmission, pathogenesis, immunology, diagnosis and therapeutics. Mol Cell Biochem. 2023; 478(9):2097-110.
doi: 10.1007/s11010-022-04657-0 pmid: 36626099 |
| 6 | World Health Organization. Mpox (Monkeypox) outbreak: global trends. Available at: https://worldhealthorg.shinyapps.io/mpx_global/ |
| 7 |
Gessain A, Nakoune E, Yazdanpanah Y. Monkeypox. N Engl J Med. 2022; 387(19):1783-93.
doi: 10.1056/NEJMra2208860 |
| 8 |
Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M, et al. A tale of two clades: monkeypox viruses. J Gen Virol. 2005; 86(Pt 10):2661-72.
doi: 10.1099/vir.0.81215-0 pmid: 16186219 |
| 9 |
Gupta AK, Talukder M, Rosen T, Piguet V. Differential diagnosis, prevention, and treatment of mpox (monkeypox): a review for dermatologists. Am J Clin Dermatol. 2023; 24(4):541-56.
doi: 10.1007/s40257-023-00778-4 |
| 10 |
Rani I, Satapathy P, Goyal A, Shamim MA, Pal A, Squitti R, et al. Viral loads in skin samples of patients with monkeypox virus infection: a systematic review and meta-analysis. Viruses. 2023; 15(6):1386.
doi: 10.3390/v15061386 |
| 11 |
Gurnani B, Kaur K, Chaudhary S, Balakrishnan H. Ophthalmic manifestations of monkeypox infection. Indian J Ophthalmol. 2023; 71(5):1687-97.
doi: 10.4103/ijo.IJO_2032_22 pmid: 37203020 |
| 12 |
Mitjà O, Ogoina D, Titanji BK, Galvan C, Muyembe JJ, Marks M, et al. Monkeypox. Lancet. 2023; 401(10370):60-74.
doi: 10.1016/S0140-6736(22)02075-X |
| 13 |
Chenchula S, Ghanta MK, Amerneni KC, Rajakarunakaran P, Chandra MB, Chavan M, et al. A systematic review to identify novel clinical characteristics of monkeypox virus infection and therapeutic and preventive strategies to combat the virus. Arch Virol. 2023; 168(7):195.
doi: 10.1007/s00705-023-05808-4 pmid: 37386209 |
| 14 |
Crosato V, Degli Antoni M, Izzo I, Cerini C, Pennati F, Gulletta M, et al. Atypical monkeypox presentation in a previously vaccinated MSM HIV-positive adult. Infection. 2023; 51(3):783-6.
doi: 10.1007/s15010-022-01967-9 pmid: 36639593 |
| 15 |
Català A, Riera J, Fuertes I. Mpox - formerly monkey pox - in dermatology: a review of epidemiologic features, clinical presentation, diagnosis, and treatment. Actas Dermosifiliogr. 2023; 114(4):318-26.
doi: 10.1016/j.ad.2023.01.002 |
| 16 |
Long B, Liang SY, Carius BM, Chavez S, Gottlieb M, Koyfman A, et al. Mimics of monkeypox: considerations for the emergency medicine clinician. Am J Emerg Med. 2023; 65:172-8.
doi: 10.1016/j.ajem.2023.01.007 |
| 17 |
Brooks KA, Neptune NS, Mattox DE. Otolaryngologic manifestations of Mpox: the Atlanta outbreak. Acta Otolaryngol. 2023; 143(3):237-41.
doi: 10.1080/00016489.2023.2182911 |
| 18 |
Studemeister L, Pai S, Walsh K, Cooper J. Acute tonsillitis due to monkeypox. J Emerg Med. 2023; 64(2):211-3.
doi: 10.1016/j.jemermed.2022.12.029 pmid: 36822985 |
| 19 | Carrubba S, Geevarghese A, Solli E, Guttha S, Sims J, Sperber L, et al. Novel severe oculocutaneous manifestations of human monkeypox virus infection and their historical analogues. Lancet Infect Dis. 2023 ;23(5): e190-e197. |
| 20 |
Zong Y, Kamoi K, Zhang J, Yang M, Ohno-Matsui K. Mpox (monkeypox) and the eye: ocular manifestation, diagnosis, treatment and vaccination. Viruses. 2023; 15(3): 616.
doi: 10.3390/v15030616 |
| 21 |
Whealon C. Mpox masquerading as secondary syphilis. Adv Emerg Nurs J. 2023; 45(2):109-18.
doi: 10.1097/TME.0000000000000458 pmid: 37106494 |
| 22 |
Farrar JL, Lewis NM, Houck K, Canning M, Fothergill A, Payne AB, et al. Demographic and clinical characteristics of mpox in persons who had previously received 1 dose of JYNNEOS vaccine and in unvaccinated persons—29 U.S. jurisdictions, may 22-September 3, 2022. Am J Transplant. 2023; 23(2):298-303.
doi: 10.1016/j.ajt.2023.01.003 |
| 23 |
van Nispen C, Reffett T, Long B, Gottlieb M, Frawley TC. Diagnosis and management of monkeypox: a review for the emergency clinician. Ann Emerg Med. 2023; 81(1):20-30.
doi: 10.1016/j.annemergmed.2022.07.014 |
| 24 |
Peris MP, Clusa L, Alonso H, Escolar C, Fortuño B, Rezusta A, et al. Clinical performance evaluation of a rapid real-time PCR assay for monkeypox diagnosis: a retrospective and comparative study. Microbiol Spectr. 2023; 11(3):e0051023.
doi: 10.1128/spectrum.00510-23 |
| 25 |
Allan-Blitz LT, Gandhi M, Adamson P, Park I, Bolan G, Klausner JD. A position statement on mpox as a sexually transmitted disease. Clin Infect Dis. 2023; 76(8):1508-12.
doi: 10.1093/cid/ciac960 |
| 26 |
Money KM, Barnett TA, Rapaka S, Osborn R, Kitani T, Fuguet D, et al. Monkeypox-associated central nervous system disease: a case series and review. Ann Neurol. 2023; 93(5):893-905.
doi: 10.1002/ana.v93.5 |
| 27 |
Shamim MA, Padhi BK, Satapathy P, Veeramachaneni SD, Chatterjee C, Tripathy S, et al. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review. Int J Infect Dis. 2023; 127:150-61.
doi: 10.1016/j.ijid.2022.11.040 |
| 28 | Fox T, Gould S, Princy N, Rowland T, Lutje V, Kuehn R. Therapeutics for treating mpox in humans. Cochrane Database Syst Rev. 2023; 3(3):CD015769. |
| 29 |
Cabanillas B, Murdaca G, Guemari A, Torres MJ, Azkur AK, Aksoy E, et al. A compilation answering 50 questions on monkeypox virus and the current monkeypox outbreak. Allergy. 2023; 78(3):639-62.
doi: 10.1111/all.15633 pmid: 36587287 |
| 30 |
Deputy NP, Deckert J, Chard AN, Sandberg N, Moulia DL, Barkley E, et al. Vaccine effectiveness of JYNNEOS against mpox disease in the United States. N Engl J Med. 2023; 388(26):2434-43.
doi: 10.1056/NEJMoa2215201 |
| 31 | Rosenberg ES, Dorabawila V, Hart-Malloy R, Anderson BJ, Miranda W, O’Donnell T, et al. Effectiveness of JYNNEOS vaccine against diagnosed mpox infection - New York, 2022. MMWR Morb Mortal Wkly Rep. 2023; 72(20):559-63. |
| 32 |
Pinto P, Costa MA, Gonçalves MFM, Rodrigues AG, Lisboa C. Mpox person-to-person transmission-where have we got so far? A systematic review. Viruses. 2023; 15(5): 1074.
doi: 10.3390/v15051074 |
| 33 |
Amer F, Khalil HES, Elahmady M, ElBadawy NE, Zahran WA, Abdelnasser M, et al. Mpox: Risks and approaches to prevention. J Infect Public Health. 2023; 16(6):901-10.
doi: 10.1016/j.jiph.2023.04.001 |
| 34 |
Zelaya CE, Smith BP, Riser AP, Hong J, Distler S, O’Connor S, et al. Urban and rural mpox incidence among persons aged 15-64 years - United States, May 10-December 31, 2022. MMWR Morb Mortal Wkly Rep. 2023; 72(21):574-8.
doi: 10.15585/mmwr.mm7221a2 |
| 35 |
Aden D, Zaheer S, Kumar R, Ranga S. Monkeypox (Mpox) outbreak during COVID-19 pandemic-past and the future. J Med Virol. 2023; 95(4):e28701.
doi: 10.1002/jmv.v95.4 |
| 36 | Alonso-Cadenas JA, Andina-Martínez D, García-García CJ, Gaitero-Tristán J, García-Ascaso MT, Torrelo A. Monkeypox disease in a breastfeeding infant. Pediatr Dermatol. 2023; 40(1):214-5. |
| 37 |
Lewis RF, Kuppalli K, Hoxha A, Doherty MC, WHO mpox response incident management team. Emergency committee recommendations on mpox - what’s next? Bull World Health Organ. 2023; 101(5):300-300A.
doi: 10.2471/BLT.00.000000 |
| 38 |
Laurenson-Schafer H, Sklenovská N, Hoxha A, Kerr SM, Ndumbi P, Fitzner J, et al. Description of the first global outbreak of mpox: an analysis of global surveillance data. Lancet Glob Health. 2023; 11(7):e1012-e1023.
doi: 10.1016/S2214-109X(23)00198-5 pmid: 37349031 |
| 39 | Chastain DB, Motoa G, Ortiz-Martínez Y, Gharamti A, Henao-Martínez AF. Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohort. AIDS. 2023; 37(4):611-6. |
| 40 |
Mellou K, Tryfinopoulou K, Pappa S, Gkolfinopoulou K, Papanikou S, Papadopoulou G, et al. Overview of mpox outbreak in Greece in 2022-2023: is it over? Viruses. 2023; 15(6):1384.
doi: 10.3390/v15061384 |
| 41 |
Mailhe M, Beaumont AL, Thy M, Le Pluart D, Perrineau S, Houhou-Fidouh N, et al. Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study. Clin Microbiol Infect. 2023; 29(2):233-9.
doi: 10.1016/j.cmi.2022.08.012 |
| 42 | Mathew T, Duffy E, Smit E, Harrower J, Oliphant J, Bunkley N, et al. A clinical review of mpox for the Aotearoa New Zealand clinician. N Z Med J. 2023; 136(1570):61-8. |
| 43 | Ramírez-Soto MC. Monkeypox outbreak in Peru. Medicina (Kaunas). 2023; 59(6):1096. |
| 44 |
Islam MR, Haque MA, Ahamed B, Tanbir M, Khan MR, Eqbal S, et al. Assessment of vaccine perception and vaccination intention of mpox infection among the adult males in Bangladesh: a cross-sectional study findings. PLoS One. 2023; 18(6):e0286322.
doi: 10.1371/journal.pone.0286322 |
| 45 |
Das SK, Bhattarai A, Kc S, Shah S, Paudel K, Timsina S, et al. Socio-demographic determinants of the knowledge and attitude of Nepalese healthcare workers toward human monkeypox: a cross-sectional study. Front Public Health. 2023; 11:1161234.
doi: 10.3389/fpubh.2023.1161234 |
| 46 |
Ren FM, Liu JC, Miao JP, Xu YC, Zhang RY, Fan JJ, et al. Public awareness, specific knowledge, and worry about mpox (monkeypox): a preliminary community-based study in Shenzhen, China. Front Public Health. 2023; 11:1077564.
doi: 10.3389/fpubh.2023.1077564 |
| 47 |
Wang BY, Peng X, Li YW, Fu LW, Tian T, Liang BY, et al. Perceptions, precautions, and vaccine acceptance related to monkeypox in the public in China: a cross-sectional survey. J Infect Public Health. 2023; 16(2):163-70.
doi: 10.1016/j.jiph.2022.12.010 |
| 48 |
Kato M, Yoshimatsu F, Saito T. Trends in media coverage during the monkeypox outbreak: content analysis. J Med Internet Res. 2023; 25:e45787.
doi: 10.2196/45787 |
| 49 |
Edinger A, Valdez D, Walsh-Buhi E, Trueblood JS, Lorenzo-Luaces L, Rutter LA, et al. Misinformation and public health messaging in the early stages of the mpox outbreak: mapping the twitter narrative with deep learning. J Med Internet Res. 2023; 25:e43841.
doi: 10.2196/43841 |
| 50 |
Liverpool L. ‘The disease will be neglected’: scientists react to the WHO ending mpox emergency. Nature. 2023; 617(7962):662-3.
doi: 10.1038/d41586-023-01581-1 |
| [1] | George Briassoulis, Mina Argyrakopoulou, Dafni Korela, Sotiria Labrinaki, Artemis Nikiforou, Antonios Papoutsakis, Panagiotis Briassoulis, Marianna Miliaraki, George Notas, Stavroula Ilia. Lifelong training, retraining, reskilling, upskilling and knowledge gaps in emergency medicine: a cross-sectional survey study [J]. World Journal of Emergency Medicine, 2025, 16(3): 212-219. |
| [2] | Qingyuan Liu, Yixin Zhang, Jian Sun, Kaipeng Wang, Yueguo Wang, Yulan Wang, Cailing Ren, Yan Wang, Jiashan Zhu, Shusheng Zhou, Mengping Zhang, Yinglei Lai, Kui Jin. Early identification of high-risk patients admitted to emergency departments using vital signs and machine learning [J]. World Journal of Emergency Medicine, 2025, 16(2): 113-120. |
| [3] | Ping Cui, Tingting Wen, Bingduo Wang, Shuijing Wu, Shiyu Chen, Xiangming Fang, TILP consortium. Tracheal intubation in the lateral position in emergency medicine: a narrative review and clinical protocol [J]. World Journal of Emergency Medicine, 2025, 16(2): 103-112. |
| [4] | Tianpeng Hu, Yan Li, Shengtao Yan, Lichao Sun, Rui Lian, Jieqiong Yu, Jie Chen, Xiaoyu Liu, Guoqiang Zhang. Application of myxovirus resistance protein A in the etiological diagnosis of infections in adults [J]. World Journal of Emergency Medicine, 2025, 16(1): 35-42. |
| [5] | Mümin Murat Yazici, Özcan Yavaşi̇. Effect of a cervical collar on optic nerve sheath diameter in trauma patients [J]. World Journal of Emergency Medicine, 2024, 15(2): 126-130. |
| [6] | Yangyang Guo, Yaqi Sun, Hongxia Wu, Jian Lu, Yuan Lin, Jiaqing Zhu, Meihong Lai, Meiqi Zhang, Jun Wang, Jungang Zheng. Protective effect and mechanism of nanoantimicrobial peptide ND-C14 against Streptococcus pneumoniae infection [J]. World Journal of Emergency Medicine, 2024, 15(1): 28-34. |
| [7] | Xinlei Wang, Yao Sun, Xiaoyu Ni, Shu Zhang. Development and validation of an emergency bloodstream infection score for predicting in-hospital mortality in patients with community-acquired bloodstream infections [J]. World Journal of Emergency Medicine, 2023, 14(4): 280-286. |
| [8] | Chun Zhao, Mei-yun Xin, Jing Li, Jin-fang Zhao, Yu-juan Wang, Wei Wang, Qian Gao, Jie Chen, Qi-wei Wang, You-peng Jin. Comparing the precision of the pSOFA and SIRS scores in predicting sepsis-related deaths among hospitalized children: a multi-center retrospective cohort study [J]. World Journal of Emergency Medicine, 2022, 13(4): 259-265. |
| [9] | Xin Lu, Shi Feng, Shi-gong Guo, Mu-bing Qin, Xiang-ning Liu, Shi-yuan Yu, Li-na Zhao, Zeng-zheng Ge, Jing-jing Chai, Sheng-yong Xu, Di Shi, Ji-hai Liu, Hua-dong Zhu, Yi Li. Development of an intensive simulating training program in emergency medicine for medical students in China [J]. World Journal of Emergency Medicine, 2022, 13(1): 23-26. |
| [10] | Hong-yan Wei, Wen-jie Liang, Bin Li, Ling-yu Wei, An-qi Jiang, Wei-dong Chen, Peng-hao Guo, Jia Xu. Clinical characteristics and risk factors of Talaromyces marneffei infection in human immunodeficiency virus-negative patients: A retrospective observational study [J]. World Journal of Emergency Medicine, 2021, 12(4): 281-286. |
| [11] | Janett Kreutziger, Philip Puchner, Stefan Schmid, Wolfgang Mayer, Harald Prossliner, Wolfgang Lederer. Accuracy of training blood volume quantification using a visual estimation tool [J]. World Journal of Emergency Medicine, 2021, 12(3): 174-178. |
| [12] | Li-wei Duan, Jin-long Qu, Jian Wan, Yong-hua Xu, Yi Shan, Li-xue Wu, Jin-hao Zheng, Wei-wei Jiang, Qi-tong Chen, Yan Zhu, Jian Zhou, Wen-bo Yu, Lei Pei, Xi Song, Wen-fang Li, Zhao-fen Lin. Effects of viral infection and microbial diversity on patients with sepsis: A retrospective study based on metagenomic next-generation sequencing [J]. World Journal of Emergency Medicine, 2021, 12(1): 29-35. |
| [13] | Samantha Shwe, Lauren Witchey, Shadi Lahham, Ethan Kunstadt, Inna Shniter, John C. Fox. Retrospective analysis of eFAST ultrasounds performed on trauma activations at an academic level-1 trauma center [J]. World Journal of Emergency Medicine, 2020, 11(1): 12-17. |
| [14] | Yi-wen Fan, Shao-wei Jiang, Jia-meng Chen, Hui-qi Wang, Dan Liu, Shu-ming Pan, Cheng-jin Gao. A pulmonary source of infection in patients with sepsis-associated acute kidney injury leads to a worse outcome and poor recovery of kidney function [J]. World Journal of Emergency Medicine, 2020, 11(1): 18-26. |
| [15] | Elaine Situ-LaCasse, Helpees Guirguis, Lucas Friedman, Asad E. Patanwala, Seth E. Cohen, Srikar Adhikari. Can emergency physicians perform extended compression ultrasound for the diagnosis of lower extremity deep vein thrombosis? [J]. World Journal of Emergency Medicine, 2019, 10(4): 205-209. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
